Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
You need to sign in or sign up before continuing.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Regulus Therapeutics Inc. buy SVB Leerink LLC

Regulus Therapeutics Inc.
Start price
€2.10
18.03.24 / 50%
Target price
€5.51
18.03.25
Performance (%)
-40.48%
End price
€1.25
19.03.25
Summary
This prediction ended on 19.03.25 with a price of €1.25. Massive losses of -40.48% were the result for the BUY prediction by SVB_Leerink_LLC. SVB_Leerink_LLC has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Regulus Therapeutics Inc. - - -
iShares Core DAX® 0,44 % 5,64 % 7,81 %
iShares Nasdaq 100 1,06 % 0,28 % 27,24 %
iShares Nikkei 225® 1,77 % 0,41 % 49,27 %
iShares S&P 500 0,37 % 1,92 % 22,34 %

Comments by SVB_Leerink_LLC for this prediction

In the thread Regulus Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -40.48%
Target price 5.509
Change
Ends at 18.03.25

Regulus Therapeutics Inc. (NASDAQ: RGLS) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $6.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat

SVB Leerink LLC 
0
Report Share
18.03.24
In the thread Trading Regulus Therapeutics Inc.
Prediction Buy
Perf. (%) -40.48%
Target price 5.509
Change
Ends at 18.03.25

Die von SVB_Leerink_LLC gewählte maximale Laufzeit wurde überschritten

SVB Leerink LLC 
0
Report Share
19.03.25